LDXLUMOS DIAGNOSTICS HOLDINGS LIMITED

Announcement history available from 1 August 2025

Fromto

Date / Time	Title	Type	MS	Report Codes
7 Aug 2026, 21:02	Lumos to Present at 20th Bioshares Biotech Summit	Presentations	—	03026
4 Aug 2026, 19:04	Lumos Receives FebriDx Order from PHASE Scientific	Company Update	MS	11001
30 July 2026, 19:38	Lumos Secures Distribution for FebriDx in Romania	Company Update	—	11001
28 July 2026, 22:42	Change of Director's Interest Notice - DW	Director Interests	—	02009
28 July 2026, 19:40	Section 708A Cleansing Statement	Securities Administration	—	06018
28 July 2026, 19:37	Application for quotation of securities - LDX	Other	—	06020
27 July 2026, 22:01	Investor Presentation	Presentations	—	03026, 14014
27 July 2026, 19:55	Quarterly Activities/Appendix 4C Cash Flow Report	Quarterly Reports	MS	14014, 19004, 19009
21 July 2026, 22:08	FebriDx Commercial Traction Across Priority US Accounts	Company Update	MS	11001
20 July 2026, 21:01	Q4 FY26 Results Release Date and Webinar Invitation	Other	—	03027
20 July 2026, 20:50	Investor Information Sessions	Company Administration	—	12008
14 July 2026, 23:06	Notification of cessation of securities - LDX	Other	—	06027
3 July 2026, 00:27	Closure of A$5M Loan Facility with Major Shareholders	Capital Raising	—	03022
29 June 2026, 19:54	Lumos Receives Research & Development Tax Rebate	Periodic Reports	MS	03014
25 June 2026, 21:48	Change of Director's Interest Notice - SL	Director Interests	—	02009
22 June 2026, 22:12	Application for quotation of securities - LDX	Other	—	06020
19 June 2026, 19:13	Change of Director's Interest Notice - CR	Director Interests	—	02009
11 June 2026, 19:58	Investor Presentation - FebriDx US Commercial Update	Presentations	—	03026
6 June 2026, 00:51	Change of Director's Interest Notice - DW	Director Interests	—	02009
4 June 2026, 21:23	FebriDx US Commercial Update Webinar Invitation	Presentations	—	14014
20 May 2026, 23:24	Application for quotation of securities - LDX	Other	—	06020
20 May 2026, 23:24	Section 708A Cleansing Statement	Securities Administration	—	06018
18 May 2026, 21:42	FebriDx U.S. Rollout and Reimbursement Update - Amended	Company Update	MS	11001
18 May 2026, 19:49	FebriDx U.S. Rollout and Reimbursement Update	Company Update	MS	11001
14 May 2026, 19:37	FebriDx Paediatric Study Enrolment Milestone Achieved	Company Update	MS	11001
8 May 2026, 00:02	Lumos receives US$0.5m CLIA waiver milestone payment	Periodic Reports	—	03014
1 May 2026, 21:16	Change of Director's Interest Notice - CR	Director Interests	—	02009
1 May 2026, 21:16	Change of Director's Interest Notice - SL	Director Interests	—	02009
1 May 2026, 21:11	Notification regarding unquoted securities - LDX	Other	—	06021
1 May 2026, 21:10	Notification regarding unquoted securities - LDX	Other	—	06021
1 May 2026, 21:08	Application for quotation of securities - LDX	Other	—	06020
1 May 2026, 21:04	Results of Share Purchase Plan	Capital Raising	—	06017
1 May 2026, 02:23	Change of Director's Interest Notice - SL	Director Interests	—	02009
21 Apr 2026, 20:32	Q3 FY26 Results Investor Presentation	Quarterly Reports	—	03026, 19003
20 Apr 2026, 19:49	Quarterly Activities/Appendix 4C Cash Flow Report	Quarterly Reports	MS	19003, 19008
16 Apr 2026, 19:33	Notification of cessation of securities - LDX	Other	—	06027
16 Apr 2026, 02:26	Lumos Q3 FY26 Results Webinar Invitation	Capital Raising	—	03027, 06017, 14014
15 Apr 2026, 00:35	Lumos expands WellStreet Urgent Care locations	Company Update	—	11001
14 Apr 2026, 20:14	Change in substantial holding from RYD	Substantial Holders	—	02002
14 Apr 2026, 19:13	Lumos receives US$5m FebriDx milestone payment from PHASE	Company Update	—	11001
11 Apr 2026, 03:31	Response to ASX Aware Letter	ASX Query	MS	17003
10 Apr 2026, 19:32	Target Market Determination	Other	—	14001
10 Apr 2026, 19:31	Prospectus	Securities Administration	MS	06010
10 Apr 2026, 19:30	SPP - Letter to Eligible Shareholders	Capital Raising	—	06017, 16002
9 Apr 2026, 22:10	Application for quotation of securities - LDX	Other	—	06020
9 Apr 2026, 22:10	Section 708A Cleansing Statement	Securities Administration	—	06018
9 Apr 2026, 22:06	Application for quotation of securities - LDX	Other	—	06020
9 Apr 2026, 22:05	Section 708A Cleansing Statement	Securities Administration	—	06018
8 Apr 2026, 19:45	Lumos secures new contract manufacturing agreement	Company Update	MS	11001
2 Apr 2026, 23:01	Section 708A Cleansing Statement	Securities Administration	—	06018

1–50 of 116

Rows

1 / 3